Dr Bleier explains why for him working with Industry is a critical step to advancing investigator-initiated work to broader patient care.
Michael Donabedian presents how Vetoquinol collaborates with Academic partners
External innovation and collaboration with Academia
Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface
In response to the dual challenges of increasingly risky target portfolios and realignment of traditional pharmaceutical company resources away from early-phase research and development (R&D), research groups have sought to...